Abbott Labs Files Patent Suit Against ImClone

Law360, New York (February 6, 2007, 12:00 AM EST) -- Drug maker Abbott Laboratories Inc. has filed a patent infringement lawsuit against ImClone Systems Inc., accusing its rival of infringing a method patent in the manufacture of its costly cancer drug Erbitux.

The lawsuit, filed Feb. 5 in Massachusetts district court, accuses New York-based ImClone of directly and indirectly trampling Abbott’s patent related to cellular enhancer sequences used in drug manufacturing.

According to the lawsuit, the “extraordinary discovery” disclosed in the patent-in-suit is embodied in a certain cell line dubbed C225, which is used to make...
To view the full article, register now.